Source: Fortune.com
Summary
Joyce Rubinger, a nurse practitioner, faced legal action after allegedly prescribing over 260,000 controlled substances to patients across 20 states, including athletes and others. The DEA revoked her ability to prescribe opioids, citing “egregious conduct.” She agreed to pay $1.4 million to settle a Justice Department civil complaint, without admitting wrongdoing. The case included allegations of prescribing to a street gang member, a drug trafficker, and a model. Rubinger’s clients included NFL and NBA stars, though none were accused of wrongdoing. The DEA said she took steps to avoid detection, including coaching clients on how to evade pharmacy alerts.
Our Reading
The numbers tell one story.
Rubinger prescribed 260,000 pills over four years, including to athletes and gang members.
She coached clients on how to avoid DEA detection, calling it “like buying a burger at McDonald’s.”
Her practice operated out of hotel rooms without medical records or physician oversight.
The DEA called her conduct “covert and slinking.”
Author: Evan Null
Joan Rubinger’s Rise and Fall
Joan Rubinger, a former elite athlete, overcame a severe biking accident that left her paralyzed. She became a pain-relief specialist, helping top athletes return to their sports. Her website listed 169 NFL Pro Bowl selections, 29 NBA and WNBA champions, and 15 Olympic medalists as clients. Among her notable patients were NBA All Stars Kobe Bryant and Dwyane Wade, as well as MLB All Star Fernando Tatis Jr.
Rubinger’s practice, All Pro Sports Medicine, gained attention for its discreet approach. She operated out of hotel rooms and marketed a pain-relieving gel called “The Goo.” Her website featured testimonials from athletes like Drew Brees and Saquon Barkley. However, her success was marred by allegations of illegal opioid prescriptions.
The DEA alleged that Rubinger prescribed thousands of controlled substances to patients in over 20 states. She was accused of dispensing opioids like oxycodone, Percocet, and Xanax without a legitimate medical purpose. The DEA described her actions as a “covert and slinking” scheme. In March, she agreed to pay $1.4 million to settle a Justice Department civil complaint, without admitting wrongdoing.
Rubinger’s case did not result in criminal charges, but the DEA revoked her ability to prescribe opioids. She was also accused of taking steps to avoid DEA suspicion, including coaching clients on how to avoid having their prescriptions flagged by pharmacies. The DEA described her conduct as especially flagrant, given the volume of pills and the methods used to evade detection.
Rubinger’s story highlights the complexities of the opioid crisis and the challenges of regulating medical professionals. While she helped many athletes, her actions put patients at risk and led to legal consequences. The case also raises questions about the role of nurse practitioners in prescribing controlled substances and the need for oversight in medical practices.
The DEA’s Role and Legal Consequences
The DEA played a significant role in uncovering Rubinger’s alleged illegal activities. The agency alleged that she prescribed controlled substances to a wide range of clients, including members of an Ohio-based street gang, a confessed New Jersey drug trafficker, and a New York City model. The DEA described her actions as a “covert and slinking” scheme, highlighting the extent of her alleged misconduct.
Rubinger’s case did not result in criminal charges, but the DEA revoked her ability to prescribe opioids. She also agreed to pay $1.4 million to settle a Justice Department civil complaint. The settlement did not include an admission of wrongdoing, and she agreed to never again prescribe controlled substances. The DEA cited what an administrative law judge called “egregious conduct” as the reason for revoking her prescribing privileges.
The DEA’s actions were part of a broader effort to combat the opioid crisis. The agency emphasized the importance of protecting the public from the unlawful dispensing of dangerous drugs. The case also highlighted the need for greater oversight of medical professionals, particularly those prescribing controlled substances.
Rubinger’s case was not the first of its kind, but it stood out due to the volume of pills and the methods used to evade detection. The DEA described her actions as especially flagrant, noting that she took steps to avoid suspicion, including coaching clients on how to avoid having their prescriptions flagged by pharmacies.
The case also raised questions about the role of nurse practitioners in prescribing controlled substances. While Rubinger held a master’s degree in nursing and kinesiology, she was not a doctor and was not allowed to prescribe opioids without physician supervision. The DEA’s actions underscored the importance of adhering to medical regulations and the potential consequences of violating them.
Client List and Public Perception
Rubinger’s client list included some of the most recognizable names in sports, including NFL and NBA stars. The DEA alleged that she prescribed controlled substances to a wide range of clients, including members of an Ohio-based street gang, a confessed New Jersey drug trafficker, and a New York City model. Despite these allegations, many of her clients were not accused of wrongdoing, and their statements of support predated the Justice Department complaint.
The DEA’s actions were part of a broader effort to combat the opioid crisis. The agency emphasized the importance of protecting the public from the unlawful dispensing of dangerous drugs. The case also highlighted the need for greater oversight of medical professionals, particularly those prescribing controlled substances.
Rubinger’s case was not the first of its kind, but it stood out due to the volume of pills and the methods used to evade detection. The DEA described her actions as especially flagrant, noting that she took steps to avoid suspicion, including coaching clients on how to avoid having their prescriptions flagged by pharmacies.
The case also raised questions about the role of nurse practitioners in prescribing controlled substances. While Rubinger held a master’s degree in nursing and kinesiology, she was not a doctor and was not allowed to prescribe opioids without physician supervision. The DEA’s actions underscored the importance of adhering to medical regulations and the potential consequences of violating them.
Rubinger’s story highlights the complexities of the opioid crisis and the challenges of regulating medical professionals. While she helped many athletes, her actions put patients at risk and led to legal consequences. The case also raises questions about the role of nurse practitioners in prescribing controlled substances and the need for oversight in medical practices.
Legal and Ethical Implications
Rubinger’s case raised significant legal and ethical questions about the responsibilities of medical professionals. The DEA alleged that she prescribed controlled substances without a legitimate medical purpose, putting patients at risk. The case also highlighted the importance of adhering to medical regulations and the potential consequences of violating them.
The DEA’s actions were part of a broader effort to combat the opioid crisis. The agency emphasized the importance of protecting the public from the unlawful dispensing of dangerous drugs. The case also highlighted the need for greater oversight of medical professionals, particularly those prescribing controlled substances.
Rubinger’s case was not the first of its kind, but it stood out due to the volume of pills and the methods used to evade detection. The DEA described her actions as especially flagrant, noting that she took steps to avoid suspicion, including coaching clients on how to avoid having their prescriptions flagged by pharmacies.
The case also raised questions about the role of nurse practitioners in prescribing controlled substances. While Rubinger held a master’s degree in nursing and kinesiology, she was not a doctor and was not allowed to prescribe opioids without physician supervision. The DEA’s actions underscored the importance of adhering to medical regulations and the potential consequences of violating them.
Rubinger’s story highlights the complexities of the opioid crisis and the challenges of regulating medical professionals. While she helped many athletes, her actions put patients at risk and led to legal consequences. The case also raises questions about the role of nurse practitioners in prescribing controlled substances and the need for oversight in medical practices.
Impact on the NFL and Sports Medicine
Rubinger’s case had a significant impact on the NFL and the broader sports medicine industry. The league has long struggled with painkiller use, with a 2011 study finding that 52% of retired players used opioids during their careers. More recently, the NFL faced scrutiny over the illegal distribution of oxycodone by a head trainer for the Washington Commanders.
The NFL has since implemented more rigorous accounting of drug prescriptions. Players are now required to report any prescriptions they receive from outside their team. However, the case of Rubinger highlights the ongoing challenges of regulating medical professionals and ensuring the safe use of controlled substances.
Rubinger’s case also raised questions about the role of nurse practitioners in sports medicine. While she was not a doctor, she was allowed to prescribe opioids under certain conditions. The DEA’s actions underscored the importance of adhering to medical regulations and the potential consequences of violating them.
The case also highlighted the need for greater transparency in sports medicine. The NFL Players Association and other organizations have called for more oversight of medical professionals who treat athletes. The case of Rubinger serves as a cautionary tale about the risks of unregulated medical practices.
Rubinger’s story is a reminder of the complex relationship between sports, medicine, and the opioid crisis. While she helped many athletes, her actions put patients at risk and led to legal consequences. The case also raises important questions about the role of medical professionals in sports and the need for greater oversight in the industry.
